Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance (Q39336478)

11 September 2017

title

Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistance (English)

1 reference

11 September 2017

1 reference

Shanghua Yin

1

1 reference

11 September 2017

Changqing Zeng

series ordinal

2

1 reference

11 September 2017

Malathi Hari

series ordinal

3

1 reference

11 September 2017

Fernando Cabral

series ordinal

4

1 reference

11 September 2017

publication date

6 June 2012

1 reference

11 September 2017

published in

Pharmaceutical Research

1 reference

11 September 2017

volume

29

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

2994-3006

1 reference

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Are tubulin isotypes functionally significant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Nucleotide sequences of three different isoforms of beta-tubulin cDNA from Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Complete sequence of three alpha-tubulin cDNAs in Chinese hamster ovary cells: each encodes a distinct alpha-tubulin isoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Microtubule dynamics as a target in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Structural basis for the regulation of tubulin by vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

High-resolution model of the microtubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A unique mode of microtubule stabilization induced by peloruside A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Microtubule-binding agents: a dynamic field of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Do beta-tubulin mutations have a role in resistance to chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Human mutations that confer paclitaxel resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A mutation in beta-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Molecular mechanisms of patupilone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mechanisms of Taxol resistance related to microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations affecting beta-tubulin folding and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations affecting assembly and stability of tubulin: evidence for a nonessential beta-tubulin in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Overexpression of an epitope-tagged beta-tubulin in Chinese hamster ovary cells causes an increase in endogenous alpha-tubulin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

alpha-Tubulin limits its own synthesis: evidence for a mechanism involving translational repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations in alpha- and beta-tubulin affect spindle formation in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Resistance to antimitotic agents as genetic probes of microtubule structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Cell line-specific differences in the control of cell cycle progression in the absence of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Isolation of Chinese hamster ovary cell mutants requiring the continuous presence of taxol for cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Taxol-requiring mutant of Chinese hamster ovary cells with impaired mitotic spindle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Refined structure of alpha beta-tubulin at 3.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Mutations in the neuronal ß-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0794-5

Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin

21 January 2018

1 reference

12 December 2020

Missense mutations at lysine 350 in beta 2-tubulin confer altered sensitivity to microtubule inhibitors in Chlamydomonas

1 reference

12 December 2020

Biochemical genetic analysis of indanocine resistance in human leukemia.

1 reference

12 December 2020

A mechanism of cellular resistance to drugs that interfere with microtubule assembly

1 reference

12 December 2020

The roles of beta-tubulin mutations and isotype expression in acquired drug resistance

1 reference

12 December 2020

Expression and function of beta-tubulin isotypes in Chinese hamster ovary cells.

1 reference

12 December 2020

Multiple forms of tubulin: different gene products and covalent modifications

1 reference

12 December 2020

Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel.

1 reference

12 December 2020

Mutations in the β-tubulin binding site for peloruside A confer resistance by targeting a cleft significant in side chain binding

1 reference

12 December 2020

Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.

1 reference

12 December 2020

CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin

1 reference

12 December 2020

Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.

1 reference

12 December 2020

Factors determining cellular mechanisms of resistance to antimitotic drugs

1 reference

12 December 2020

New insights into mechanisms of resistance to microtubule inhibitors

1 reference

12 December 2020

10.1007/S11095-012-0794-5

Identifiers

DOI

1 reference

11 September 2017

1 reference